课题基金 / 基金详情

Regulation of Innate Dendritic Cell CTLA-4

Regulation of Innate Dendritic Cell CTLA-4
先天树突状细胞 CTLA-4 的调节
批准号:
10747694
负责人:
WILLIAM Karl DECKER
金额:
$47.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-03-13 至 2028-06-30
关键词:
ATAC-seqAblationAdoptive TransferAgeAlopeciaAnimalsAntigensAutoimmune DiseasesB-LymphocytesBindingBiologicalC57BL/6 MouseCCAAT-Enhancer-Binding ProteinsCD8-Positive T-LymphocytesCD8B1 geneCTLA4 geneCell CommunicationCell ProliferationCell SeparationCell secretionCellsCellular ImmunityCellular biologyCessation of lifeChIP-seqCoculture TechniquesCommunicable DiseasesComplexCuesDataDendritic CellsDetectionDiseaseDown-RegulationEquilibriumEventExhibitsFailure to ThriveFormulationFundingGATA3 geneGenetic TranscriptionGenomicsHealthHumanITGAX geneImmuneImmune responseImmune systemIn VitroIncubatedInfectious AgentInterferon Type IIInterventionKnock-outLoxP-flanked alleleLymphocytic InfiltrateLymphoidLymphoid TissueMalignant NeoplasmsMass Spectrum AnalysisMediatingMusMyelogenousMyeloid CellsNatural ImmunityPancreasPathway interactionsPeripheralPeripheral Blood Mononuclear CellPersonal SatisfactionPeyer&aposs PatchesPharmacologic SubstancePhenotypePlayPopulationProcessProliferatingProteinsPublishingRegulationRegulatory T-LymphocyteResolutionRoleShapesSignal TransductionSmall Interfering RNAT-LymphocyteTestingThymus GlandTissuesTranscriptional RegulationTreatment ProtocolsTumor ImmunityUp-RegulationVesicleVirus DiseasesWorkantiviral immunityarmcell typecentral toleranceconditional knockoutdruggable targetexosomefluorescence imagingimmune activationimmune checkpointimmune functionimmunoregulationin vivoknock-downknockout animallymphoid organmonocytenovelnovel vaccinesparacrinepolarized cellprogramspromoterresponsetherapeutic targetthymocytetranscriptome sequencingtransmission processvaccination strategy

项目摘要

项目成果

WILLIAM Karl DECKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Myeloid dendritic cells (DC) are a critical lineage of innate immunity that serve as a principal point of contact and crosstalk between the innate and adaptive arms of the immune system. CTLA-4 is one of the best characterized of the immune checkpoint proteins, molecules that serve to balance, regulate, and fine-tune immune activation with homeostatic inhibition. CTLA-4 is expressed by all major lymphoid lineage effectors; however, its function- ality has been best characterized in T-cells where it exhibits both cell-extrinsic and cell-intrinsic regulatory func- tions. Until recently, very little was known about CTLA-4 expression or function in non-lymphoid cell types, par- ticularly the myeloid lineage dendritic cell subsets. In the original iteration of this renewal application, we provided preliminary data demonstrating that DC-secreted CTLA-4+ exosomes could bind B7 in paracrine fashion, leading to vesicle internalization and subsequent downregulation of B7 expression among bystander DC that internalized the CTLA-4+ exosomes. Conversely, knockdown of DC-expressed CTLA-4 resulted in a dramatic upregulation of co-cultured CD8+ cell proliferation in vitro as well as enhanced antitumor and antiviral immunity in vivo. These discoveries and concomitant characterization of myeloid CTLA-4 expression signified a paradigm shift in the understanding of CTLA-4’s role in immune governance as well as the mechanisms through which innate and adaptive crosstalk occur. Subsequent data indicated that the expression of DC CTLA-4 is modulated in response to TH polarizing cues and that regulation in DC appears to be governed in part by the transcription factors GATA3 and C/EBP-b. Further, conditional ablation of CTLA-4 in the C57BL/6 background revealed potential new roles for DC expressed CTLA-4 in regulatory processes in the thymus and in other lymphoid tissues including Peyer’s patches. These novel and exciting data have allowed formulation of a refined overarching hypothesis that DC- secreted CTLA-4+ exosomes act as effector vehicles that shape downstream TH polarization of adaptive re- sponses as dictated by DC detection of innate signaling cues. By means of three independent aims we will test this overarching hypothesis by i) defining the role of TH polarizing cues in the governance of DC CTLA-4 expres- sion and the governance of the CEBP/b and GATA3 transcriptional regulators, ii) defining the mechanisms through which DC-secreted CTLA-4+ and CTLA-4neg exosomes regulate downstream adaptive TH polarization, and iii) defining the manner by which DC CTLA-4 expression modulates central tolerance by interrogating the regulatory T-cell deficits observed in the CD11c-Cre CTLA-4flox/flox C57BL/6 mouse. Completion of these inde- pendent aims will further elucidate the novel regulatory role of myeloid CTLA-4, furthering the ability to synthesize effective and powerful vaccination strategies while characterizing critical druggable target interactions and en- hancing the understanding of complex biological pathways.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2017.00829
发表时间: 2017
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Decker WK, da Silva RF, Sanabria MH, Angelo LS, Guimarães F, Burt BM, Kheradmand F, Paust S]
通讯作者: Paust S
DOI: 10.3389/fimmu.2020.608024
发表时间: 2020
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Oyewole-Said D, Konduri V, Vazquez-Perez J, Weldon SA, Levitt JM, Decker WK]
通讯作者: Decker WK
Innate DC Govern TH Polarization through the Novel Regulator AIMp1
  • 批准号:
    10605267
  • 项目类别:
  • 资助金额:
    $56.34万
  • 财政年份:
    2021
  • 负责人:
    WILLIAM Karl DECKER
  • 依托单位:
Innate DC Govern TH Polarization through the Novel Regulator AIMp1
  • 批准号:
    10397673
  • 项目类别:
  • 资助金额:
    $56.34万
  • 财政年份:
    2021
  • 负责人:
    WILLIAM Karl DECKER
  • 依托单位:
Regulation of Innate Dendritic Cell CTLA-4
  • 批准号:
    9882949
  • 项目类别:
  • 资助金额:
    $39.63万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM Karl DECKER
  • 依托单位:
海外基金